Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin.

Rhodniin is a highly specific inhibitor of thrombin isolated from the assassin bug Rhodnius prolixus. The 2.6 Angstrum crystal structure of the non‐covalent complex between recombinant rhodniin and bovine alpha‐thrombin reveals that the two Kazal‐type domains of rhodniin bind to different sites of thrombin. The amino‐terminal domain binds in a substrate‐like manner to the narrow active‐site cleft of thrombin; the imidazole group of the P1 His residue extends into the S1 pocket to form favourable hydrogen/ionic bonds with Asp189 at its bottom, and additionally with Glu192 at its entrance. The carboxy‐terminal domain, whose distorted reactive‐site loop cannot adopt the canonical conformation, docks to the fibrinogen recognition exosite via extensive electrostatic interactions. The rather acidic polypeptide linking the two domains is displaced from the thrombin surface, with none of its residues involved in direct salt bridges with thrombin. The tight (Ki = 2 × 10(‐13) M) binding of rhodniin to thrombin is the result of the sum of steric and charge complementarity of the amino‐terminal domain towards the active‐site cleft, and of the electrostatic interactions between the carboxy‐terminal domain and the exosite.

[1]  E. Scacheri,et al.  Novel hirudin variants from the leech Hirudinaria manillensis. Amino acid sequence, cDNA cloning and genomic organization. , 1993, European journal of biochemistry.

[2]  K. Mann,et al.  Membrane-dependent reactions in blood coagulation: role of the vitamin K-dependent enzyme complexes. , 1994, Biochimica et biophysica acta.

[3]  W. Bode,et al.  Crystal structure of the thrombin‐hirudin complex: a novel mode of serine protease inhibition. , 1990, The EMBO journal.

[4]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[5]  H. Taguchi,et al.  Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. , 1986, The Biochemical journal.

[6]  C W Turck,et al.  Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. , 1994, Biochemistry.

[7]  A. Brünger.  Free R value: a novel statistical quantity for assessing the accuracy of crystal structures , 1992, Nature.

[8]  D. Turk,et al.  The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships , 1992, Protein science : a publication of the Protein Society.

[9]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[10]  R. Huber,et al.  The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment. , 1989, The EMBO journal.

[11]  A. Tulinsky,et al.  Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors. , 1994, Biochemistry.

[12]  R. Huber,et al.  Correlation of Amino Acid Sequence with Inhibitor Activity and Specificity of Protein Inhibitors of Serine Proteinases , 1981 .

[13]  C. Esmon,et al.  Glu-192----Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S V Evans,et al.  SETOR: hardware-lighted three-dimensional solid model representations of macromolecules. , 1993, Journal of molecular graphics.

[15]  J. Hofsteenge,et al.  Kinetics of the inhibition of thrombin by hirudin. , 1986, Biochemistry.

[16]  Wolfram Bode,et al.  Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution. , 2008, European journal of biochemistry.

[17]  J Deisenhofer,et al.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. , 1974, Journal of molecular biology.

[18]  R. Huber,et al.  Accurate Bond and Angle Parameters for X-ray Protein Structure Refinement , 1991 .

[19]  L. A. Kazal,et al.  Isolation of a crystalline trypsin inhibitor-anticoagulant protein from pancreas. , 1948, Journal of the American Chemical Society.

[20]  S. Stone,et al.  Primary structure and function of novel O-glycosylated hirudins from the leech Hirudinaria manillensis. , 1992, Biochemistry.

[21]  J. Hall,et al.  The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions. , 1983, Biochimica et biophysica acta.

[22]  H Brandstetter,et al.  Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics. , 1992, Journal of molecular biology.

[23]  R. Huber,et al.  Refined structure of the hirudin-thrombin complex. , 1991, Journal of molecular biology.

[24]  P. Grootenhuis,et al.  Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site. , 1993, The Journal of biological chemistry.

[25]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[26]  G J Barton,et al.  ALSCRIPT: a tool to format multiple sequence alignments. , 1993, Protein engineering.

[27]  R. Huber,et al.  The structure of a complex of recombinant hirudin and human alpha-thrombin. , 1990, Science.

[28]  C. Bon,et al.  Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: characterization and mechanism of thrombin inhibition. , 1993, Biochemistry.

[29]  H. Lemaire,et al.  A Kazal-type inhibitor with thrombin specificity from Rhodnius prolixus. , 1993, The Journal of biological chemistry.

[30]  C. Esmon,et al.  Thrombin Glu-39 restricts the P'3 specificity to nonacidic residues. , 1991, The Journal of biological chemistry.

[31]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[32]  F. Markwardt.  Coagulation inhibitors from blood-sucking animals. A new line of developing antithrombotic drugs. , 1994, Die Pharmazie.

[33]  R. Huber,et al.  Crystallization, crystal structure analysis and molecular model of the third domain of Japanese quail ovomucoid, a Kazal type inhibitor. , 1981, Journal of molecular biology.

[34]  A. Baici,et al.  Interaction of site specific hirudin variants with α‐thrombin , 1988 .

[35]  R. Huber,et al.  Natural protein proteinase inhibitors and their interaction with proteinases. , 1992, European journal of biochemistry.

[36]  W. Bode,et al.  A player of many parts: the spotlight falls on thrombin's structure. , 1993, Thrombosis research.

[37]  D. Cooper,et al.  Antithrombin III Mutation Database: First Update , 1993, Thrombosis and Haemostasis.

[38]  J. Hofsteenge,et al.  Effect of heparin on the glia-derived-nexin-thrombin interaction. , 1989, The Biochemical journal.

[39]  I. Apostol,et al.  Amino acid sequences of ovomucoid third domain from 25 additional species of birds , 1990, Journal of protein chemistry.

[40]  J. Dodt,et al.  Isolation, sequence analysis, and cloning of haemadin. An anticoagulant peptide from the Indian leech. , 1993, The Journal of biological chemistry.